Adenocarcinoma — Trials

Adenocarcinoma — Trials · CancerIndex

Clinical trials

Registered studies

9,703 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,753
Recruiting: 1,520
Ph III recruiting: 168
Growth YoY: +6.8%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 36.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,319)

clinicaltrialsPublishedShowing 1,151–1,200 of 1,522 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03261791	Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection	unknown	Phase 2	30	Shanghai Zhongshan HospitalOTHER	1	Aug 25, 2017	clinicaltrials
NCT02834169	French National Registry of Rare Peritoneal Surface Malignancies(RENAPE)	unknown	—	2,171	Hospices Civils de LyonOTHER	1	Aug 22, 2017	clinicaltrials